What We Know About Donald Trump’s COVID-19 Treatment Plan

The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, WELLESENTERPRISES

On Thursday, October 1, it was announced that President Donald Trump, First Lady Melania Trump, and other White House officials had tested positive for SARS-CoV-2. His symptoms worsened and on Friday evening, he was admitted to Walter Reed National Military Medical Center in Bethesda, Maryland.

There has been some mixed messaging with the actual timeline of when he received his diagnosis and began a treatment regimen, as The New York Times reports, and doctors can only speculate on his prognosis.

Here is what is currently known about the drugs Trump has been taking to combat his illness:

One of the first reported treatments Trump received was an experimental cocktail of two monoclonal antibodies from Regeneron. Trump was intravenously given eight grams of the cocktail, which is the highest dose used during the drug’s small, 245-person clinical trial. According to a September press release from Regeneron, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Lisa Winter

    Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 
The Immunology of the Brain

The Immunology of the Brain

Products

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo
Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit